RxDoctor Payments DataLook up a doctor →

Matthew Hummel, MD

Family Medicine · Fountain Hills, AZNPI 1780644526

Payments from drug & device makers

$107,640in general payments, 2019–2025

Across 1,120 payments — averaging $96.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$43K
  • AbbVie$30K
  • Pfizer$9K
  • Bard Peripheral Vascular, Inc.$7K
  • AstraZeneca$3K
  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • plus $13K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS10$42,705
AbbVie(2 entities)168$30,448
Pfizer55$8,705
Bard Peripheral Vascular, Inc.2$6,638
AstraZeneca127$3,015
Takeda Pharmaceuticals U.S.A., Inc.30$2,606
Amgen(2 entities)94$1,618
Lilly USA, LLC72$1,037
Eli Lilly1$1,000
GSK46$852
Boehringer Ingelheim61$756
Novo Nordisk35$610
Shionogi Inc1$600
Antares Pharma, Inc.40$567
Nestle Healthcare Nutrition Inc.31$502
Amneal Pharmaceuticals LLC24$502
Amarin Pharma, Inc.35$407
Novartis22$403
Arbor Pharmaceuticals, Inc.43$401
Boston Scientific6$341
Sumitomo Pharma America, Inc.21$328
Johnson & Johnson(2 entities)17$312
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC20$303
Esperion Therapeutics, Inc.15$268
Kowa Pharmaceuticals America, Inc.12$261
Sunovion Pharmaceuticals Inc.17$216
Akcea Therapeutics, Inc.3$212
Astellas Pharma US Inc10$179
Dexcom, Inc.4$108
Biohaven Pharmaceuticals, Inc.6$105
Azurity Pharmaceuticals, Inc.7$104
E.r. Squibb & Sons, L.L.C.5$98
Alfasigma USA, Inc.5$85
Abbott4$83
Idorsia Pharmaceuticals US Inc5$81
Clarus Therapeutics Inc.5$80
Biodelivery Sciences International, Inc.5$80
Biohaven Pharmaceutical Holding Company Ltd.4$77
Halozyme Inc4$76
Merck4$63
Aimmune Therapeutics, Inc.3$57
Acerus Pharmaceuticals Corporation3$55
Corcept Therapeutics3$53
IBSA Pharma Inc.1$53
Eisai Inc.3$50
Currax Pharmaceuticals LLC3$43
Vivus LLC2$42
Therapeuticsmd, Inc.2$40
Teva Pharmaceuticals USA, Inc.2$35
Exact Sciences2$34
Phathom Pharmaceuticals, Inc.2$34
Ironwood Pharmaceuticals, Inc2$31
Lundbeck LLC1$29
Axonics, Inc.1$26
Xeris Pharmaceuticals, Inc.1$23
Otsuka America Pharmaceutical, Inc.1$23
Aerin Medical Inc.1$19
Corium, LLC1$19
Vertical Pharmaceuticals, LLC1$19
Acorda Therapeutics, Inc1$18

How this compares

$107,640 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona →

Medicare billing

Part B allowed, 2024
$205,172
Medicare patients
354
Services billed
2,784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Fountain Hills

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →